Status:

COMPLETED

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Lead Sponsor:

EDAP TMS S.A.

Conditions:

Benign Prostatic Hyperplasia

Eligibility:

MALE

50+ years

Phase:

NA

Brief Summary

Prostate adenoma or benign prostatic hypertrophy (BPH) is a benign disease of the prostate gland. It results in an increase in the volume of the prostate area located in contact with the urethra. Comp...

Eligibility Criteria

Inclusion

  • Over 50 years of age,
  • BPH greater than 30 cc confirmed by endorectal ultrasound
  • IPSS score \> 7, Qol-IPSS \> 2, IIEF-5 score \> 11
  • Qmax \< 15 ml/s or urinary retention (in indwelling catheter, self-catheterization, or with an RPM \> 300 cc).
  • In failure or intolerance of drug treatment(s) for BPH
  • negative cytobacteriological examination of the urine

Exclusion

  • Prostate volume \> 80 ml
  • Presence of a median lobe
  • Men allergic to latex
  • Contraindication to the insertion of a transrectal HIFU probe: rectal fistula, anal or rectal fibrosis, or other abnormalities
  • History of prostate surgery
  • History of prostate radiation therapy
  • History of bladder cancer
  • Current anti-coagulant treatment with a stopping window that cannot exceed 48 hours at the time of the HIFU procedure
  • Presence of a urinary tract fistula
  • History of inflammatory bowel disease
  • Ongoing urogenital infection
  • Neurological bladder pathology
  • History of urethral stenosis
  • Confirmed or suspected prostate cancer
  • Contraindication to surgery (including anesthesia)
  • Contraindication to pelvic MRI
  • Presence of metallic implants or stents in the urethra
  • Presence of prostatic calcification whose location interferes with HIFU treatment
  • Patients with renal failure with a GFR \<35ml/min

Key Trial Info

Start Date :

September 13 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2024

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT04853914

Start Date

September 13 2021

End Date

March 31 2024

Last Update

June 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hopital Edouard Herriot, service d'urologie

Lyon, France, 69003